Pre-specified performance goals were used for statistical comparisons. The study used existing data from successful ablation procedures to identify the arrhythmia source location, then sent the ...
SAN DIEGO, February 17, 2026--(BUSINESS WIRE)--Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced the publication of a peer-reviewed study in EP ...
With this clearance, vMap’s clinical use now includes non-invasive localization of potential arrhythmia sources associated with atrial flutter mechanisms. This new capability broadens the range of ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Vektor Medical, Inc. announced that a dual-center study reports that vMap™, as part of a new, non-invasive workflow, improved efficiency and precision for ...
Vektor Medical, a medical technology company headquartered in San Diego redefining how arrhythmias are understood and treated, announced it has received the US Food and Drug Administration 510(k) ...
With this clearance, vMap’s clinical use now includes non-invasive localization of potential arrhythmia sources associated with atrial flutter mechanisms. This new capability broadens the range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results